News & Updates
Filter by Specialty:
Statins, triple antihypertensive combination may lower ICH recurrence risk
Statin therapy, as well as triple antihypertensive combination therapy, may reduce the risk of recurrence in patients who have survived an intracerebral haemorrhage (ICH), according to new local findings presented at HKMF 2023.
Statins, triple antihypertensive combination may lower ICH recurrence risk
31 May 2023
Nitrate supplements may lower risk of diabetes complications, mortality in hyperglycaemic adults
Increased levels of urinary nitrate appear to contribute to a reduction in the risk of congestive heart failure and diabetic retinopathy and may also lower the risk of death from all causes, cardiovascular disease (CVD), and diabetes in adults with hyperglycaemia, suggests a study.
Nitrate supplements may lower risk of diabetes complications, mortality in hyperglycaemic adults
30 May 2023
Serum ADMA levels linked to circadian BP variability in glaucoma
Serum levels of asymmetric dimethylarginine (ADMA) seem to play a major role in the disturbance of circadian blood pressure (BP) variability in patients with glaucoma, suggests a recent study.
Serum ADMA levels linked to circadian BP variability in glaucoma
27 May 2023
Long-term ACS outcomes similar between TiNO-coated and everolimus-eluting stents
Neither titanium-nitride-oxide (TiNO)–coated stents nor third-generation everolimus-eluting stents (EES) are necessarily better than the other in the treatment of patients with acute coronary syndromes (ACS), with a study showing no significant difference in long-term outcomes following placement of TiNO-coated stents or EES.